Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies

Journal of Thoracic and Cardiovascular Surgery

Volumn 143, Issue 3, 2012, Pages

  Biancari, Fausto ^a   Airaksinen, K E Juhani ^b   Lip, Gregory Y H ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS SURGERY; DRUG EXPOSURE; DRUG UTILIZATION; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; STROKE; SYSTEMATIC REVIEW; UNSTABLE ANGINA PECTORIS;

EID: 84857440263     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.01.069     Document Type: Article

References (41)

1. F.G. Kushner, M. Hand, S.C. Smith Jr., S.B. King 3rd, J.L. Anderson, and E.M. Antman 2009 Focused Updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
2. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 116 2007 e148 e304
3. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd, E.T. Fry, A. DeLago, and C. Wilmer Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
4. R.H. Mehta, A.Y. Chen, C.V. Pollack Jr., M.T. Roe, R.J. Zalenski, and E.A. Clements Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes Am J Cardiol 98 2006 624 627
5. Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group, eds. In: Higgins JPT, Green S, eds. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated September 2008). The Cochrane Collaboration, 2008. Available at www.cochrane-handbook.org.
6. J.S. Berger, C.B. Frye, Q. Harshaw, F.H. Edwards, S.R. Steinhubl, and R.C. Becker Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol 52 2008 1693 1701
7. E.I. Kapetanakis, D.A. Medlam, S.W. Boyce, E. Haile, P.C. Hill, and M.K. Dullum Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 26 2005 576 583
8. D.A. Fergusson, P.C. Hébert, C.D. Mazer, S. Fremes, C. MacAdams, and J.M. Murkin A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331
9. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical- epidemiology/oxford.htm. Accessed July 22, 2010.
10. E.G. Bovill, M.L. Terrin, D.C. Stump, A.D. Berke, M. Frederick, and D. Collen Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Ann Intern Med 115 1991 256 265
11. K.A. Fox, S.R. Mehta, R. Peters, F. Zhao, N. Lakkis, and B.J. Gersh Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
12. D.S. McLean, M.S. Sabatine, W. Guo, C.H. McCabe, and C.P. Cannon Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28 J Thromb Thrombolysis 24 2007 85 91
13. J. Saw, E.J. Topol, S.R. Steinhubl, D. Brennan, P.B. Berger, D.J. Moliterno CREDO Investigators Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention Am J Cardiol 94 2004 623 625
14. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. López-Sendón, G. Montalescot, and P. Theroux Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
15. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
16. P.C. Austin Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review Circ Cardiovasc Qual Outcomes 1 2008 62 67
17. G.N. Vaccarino, J. Thierer, M. Albertal, M. Vrancic, F. Piccinini, and M. Benzadón Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis J Thorac Cardiovasc Surg 137 2009 309 313
18. E.I. Kapetanakis, D.A. Medlam, K.R. Petro, E. Haile, P.C. Hill, and M.K. Dullum Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation 113 2006 1667 1674
19. S.W. Song, Y.N. Youn, G. Yi, S. Lee, and K.J. Yoo Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome Circ J 72 2008 626 632
20. F. Filsoufi, P.B. Rahmanian, J.G. Castillo, R.A. Kahn, G. Fischer, and D.H. Adams Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements J Cardiothorac Vasc Anesth 22 2008 60 66
21. C.G. Koch, L. Li, A.I. Duncan, T. Mihaljevic, D.M. Cosgrove, and F.D. Loop Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting Crit Care Med 34 2006 1608 1616
22. M. Kuduvalli, A.Y. Oo, N. Newall, A.D. Grayson, M. Jackson, and M.J. Desmond Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery Eur J Cardiothorac Surg 27 2005 592 598
23. R.H. Mehta, S. Sheng, S.M. O'Brien, F.L. Grover, J.S. Gammie, and T.B. Ferguson Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes Circ Cardiovasc Qual Outcomes 2 2009 583 590
24. Y.L. Kwak, J.C. Kim, Y.S. Choi, K.J. Yoo, Y. Song, and J.K. Shim Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery J Am Coll Cardiol 56 2010 1994 2002
25. R. Ascione, A. Ghosh, C.A. Rogers, A. Cohen, C. Monk, and G.D. Angelini In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution Ann Thorac Surg 79 2005 1210 1216
26. L. Chen, A.W. Bracey, R. Radovancevic, J.R. Cooper Jr., C.D. Collard, and W.K. Vaughn Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting J Thorac Cardiovasc Surg 128 2004 425 431
27. C.M. Dempsey, M.S. Lim, and S.G. Stacey A prospective audit of blood loss and blood transfusion in patients undergoing coronary artery bypass grafting after clopidogrel and aspirin therapy Crit Care Resusc 6 2004 248 252
28. R. Ebrahimi, C. Dyke, R. Mehran, S.V. Manoukian, F. Feit, and D.A. Cox Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 53 2009 1965 1972
29. F. Filsoufi, P.B. Rahmanian, J.G. Castillo, R.A. Kahn, G. Fischer, and D.H. Adams Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements J Cardiothorac Vasc Anesth 22 2008 60 66
30. B. Gansera, F. Schmidtler, K. Spiliopoulos, I. Angelis, P. Neumaier-Prauser, and B.M. Kemkes Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy Thorac Cardiovasc Surg 51 2003 185 189
31. R.H. Hongo, J. Ley, S.E. Dick, and R.R. Yee The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting J Am Coll Cardiol 40 2002 231 237
32. W. Kang, T.E. Theman, J.F. Reed 3rd, J. Stoltzfus, and N. Weger The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery J Surg Educ 64 2007 88 92
33. H. Karabulut, F. Toraman, S. Evrenkaya, O. Goksel, S. Tarcan, and C. Alhan Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery Eur J Cardiothorac Surg 25 2004 419 423
34. J.H. Kim, L.K. Newby, R.M. Clare, L.K. Shaw, A.J. Lodge, and P.K. Smith Clopidogrel use and bleeding after coronary artery bypass graft surgery Am Heart J 156 2008 886 892
35. J.Y. Leong, R.A. Baker, P.J. Shah, V.K. Cherian, and J.L. Knight Clopidogrel and bleeding after coronary artery bypass graft surgery Ann Thorac Surg 80 2005 928 933
36. S. Maltais, L.P. Perrault, and Q.B. Do Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery Eur J Cardiothorac Surg 34 2008 127 131
37. R.H. Mehta, M.T. Roe, J. Mulgund, E.M. Ohman, C.P. Cannon, and W.B. Gibler Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery J Am Coll Cardiol 48 2006 281 286
38. A.M. Mengistu, J. Mayer, J. Boldt, K.D. Röhm, and S.W. Suttner Usefulness of monitoring platelet function by multiple electrode aggregometry in primary coronary artery bypass surgery J Cardiothorac Vasc Anesth 25 2011 42 47 Epub 2010 Apr 27
39. F. Nurozler, T. Kutlu, G. Küük, and C. Okten Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery Interact Cardiovasc Thorac Surg 4 2005 546 549
40. G.N. Vaccarino, J. Thierer, M. Albertal, M. Vrancic, F. Piccinini, and M. Benzadón Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis J Thorac Cardiovasc Surg 137 2009 309 313
41. Y.J. Woo, T. Grand, and N. Valettas Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration Heart Surg Forum 3 2003 282 285